{"id":"NCT01190813","sponsor":"Jaeb Center for Health Research","briefTitle":"Levodopa for the Treatment of Residual Amblyopia","officialTitle":"A Randomized Trial of Levodopa as Treatment for Residual Amblyopia (ATS 17)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-09","primaryCompletion":"2014-01","completion":"2014-04","firstPosted":"2010-08-30","resultsPosted":"2015-02-13","lastUpdate":"2016-06-02"},"enrollment":139,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Amblyopia"],"interventions":[{"type":"DRUG","name":"Levodopa/Carbidopa","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"OTHER","name":"Patching","otherNames":[]}],"arms":[{"label":"Levodopa/Carbidopa","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the efficacy and safety of oral levodopa and patching versus oral placebo and patching as treatment for residual amblyopia in children 7 to \\<13 years old with visual acuity of 20/50 to 20/400 in the amblyopic eye.","primaryOutcome":{"measure":"Distribution of Amblyopic Eye Visual Acuity Change From Baseline","timeFrame":"18 weeks after enrollment","effectByArm":[{"arm":"Levodopa/Carbidopa","deltaMin":0,"sd":null},{"arm":"Placebo","deltaMin":0,"sd":null}],"pValues":[]},"eligibility":{"minAge":"7 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["25676904"],"seeAlso":["http://www.ncbi.nlm.nih.gov/pubmed/25676904","http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414716/"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":90},"commonTop":["Headache","Nausea","Nasopharyngitis","Rash","Cough"]}}